Targeting Rna With Small Molecules The 4 day event covers innovations in target identification and lead generation, which includes cancer therapies, protein degradation, induced proximity, ai machine learning, membrane proteins, translational models, synthetic biology, and other relevant topics. Discovery on target (dot) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents ranging from biologics to small molecules.
Targeting Rna With Small Molecules Now in its 8th year, the rna targeted drug discovery & development summit returns as the only dedicated industry forum addressing the unique challenges of rna targeted drug development across splice modulators, covalent drugs, proximity inducers and direct rna binders. Register & secure your spot today for this year's discovery on target. get the most out of the event by registering for one of our premium packages, or bring the team and take advantage of our group pricing discounts. For more details on the conference, please contact: tanuja koppal, phd senior conference director cambridge healthtech institute email: tkoppal@healthtech for sponsorship information, please contact: kristin skahan senior business development manager cambridge healthtech institute phone: ( 1) 781 972 5431 email: kskahan@healthtech. About the event discovery on target (dot) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic ranging from biologics to small molecules.
Targeting Rna With Small Molecules For more details on the conference, please contact: tanuja koppal, phd senior conference director cambridge healthtech institute email: tkoppal@healthtech for sponsorship information, please contact: kristin skahan senior business development manager cambridge healthtech institute phone: ( 1) 781 972 5431 email: kskahan@healthtech. About the event discovery on target (dot) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic ranging from biologics to small molecules. Cambridge healthtech institute's conference on small molecules targeting rna will highlight some of the innovative approaches being pursued to identify and modulate the right rna target. we present a method that deploys clickable probes to directly quantify protein rna interactions on proteins. The early discovery of the key roles played by these molecules explains, at least partially, this situation. yet, the last decades unraveled unexpected levels of rna transcripts with a broad. Whether you're focused on rna splice modulators, covalent binders, proximity inducing drugs, or direct rna binders this event will give you the tools and insights to fast track the discovery of functional binders and accelerate your pipeline of rna targeted small molecules to the clinic. Cambridge healthtech institute's conference on small molecules targeting rna will highlight some of the innovative approaches being pursued to identify and modulate the right rna target.
Why Now For Targeting Rna With Small Molecules Arrakis Therapeutics Cambridge healthtech institute's conference on small molecules targeting rna will highlight some of the innovative approaches being pursued to identify and modulate the right rna target. we present a method that deploys clickable probes to directly quantify protein rna interactions on proteins. The early discovery of the key roles played by these molecules explains, at least partially, this situation. yet, the last decades unraveled unexpected levels of rna transcripts with a broad. Whether you're focused on rna splice modulators, covalent binders, proximity inducing drugs, or direct rna binders this event will give you the tools and insights to fast track the discovery of functional binders and accelerate your pipeline of rna targeted small molecules to the clinic. Cambridge healthtech institute's conference on small molecules targeting rna will highlight some of the innovative approaches being pursued to identify and modulate the right rna target.
The Prospect Of Rna Targeting Using Small Molecules Arrakis Therapeutics Whether you're focused on rna splice modulators, covalent binders, proximity inducing drugs, or direct rna binders this event will give you the tools and insights to fast track the discovery of functional binders and accelerate your pipeline of rna targeted small molecules to the clinic. Cambridge healthtech institute's conference on small molecules targeting rna will highlight some of the innovative approaches being pursued to identify and modulate the right rna target.
Comments are closed.